BPC-157 Subcutaneous Injection Pen - Inject+

Australia's First
BPC-157
Subcutaneous Pen



What is BPC-157?

BPC-157 is a synthetic peptide fragment derived from a naturally occurring gastric protective protein.

It has been studied for its potential to support cellular repair, angiogenesis, and inflammatory modulation. Research suggests that BPC-157 may influence the body’s intrinsic healing processes by interacting with growth-factor receptors, nitric-oxide signalling, and cytokine regulation.

Because it acts on multiple tissue systems (vascular, connective, neural, and gastrointestinal) it is often examined for its systemic and restorative potential, not only for isolated injuries.

In Australia, BPC-157 is a Schedule 4 prescription-only peptide, available solely through compounded, pharmacy-dispensed preparations after medical consultation.

What BPC-157 is Being Studied For?

Scientific and pre-clinical studies continue to investigate BPC-157 for its effects on tissue integrity, inflammation, and organ-system recovery. Key areas of research include:

Angiogenesis and endothelial repair: Promotion of vascular endothelial growth factor (VEGF) activity and micro-capillary regeneration.
Cytokine balance: Down-regulation of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) while supporting regenerative mediators.
Fibroblast activity and collagen organisation: Improved fibroblast migration and collagen cross-linking during tissue remodelling.
Gastrointestinal barrier protection: Reinforcement of mucosal tight-junction integrity and epithelial repair.
Neuro-protective potential: Early studies examining interactions with dopaminergic and nitric-oxide systems.
Systemic recovery: Investigations into effects on tendon, ligament, endothelial, and gut–brain axis health.

All findings remain experimental; BPC-157 has not been approved by the Therapeutic Goods Administration (TGA) for therapeutic use or disease treatment.

How It’s Dispensed?

When prescribed, BPC-157 is compounded by an Australian-registered pharmacy and dispensed under pharmacist supervision.

Concentration: 2mg/mL
Volume: 3 mL pre-filled subcutaneous pen
Preservative system: Formulated in accordance with pharmacy sterility and stability standards
Temperature control: Shipped in insulated packaging with cold packs to maintain integrity during transport

Storage & Handling

Keep refrigerated as directed by the dispensing pharmacy.
Do not freeze or expose to excessive heat.
If ice packs melt during transit, this does not affect integrity within the validated shipping window.
Follow all storage and handling instructions provided with your prescription.

Usage & Administration

Administration technique, dose volume, and frequency are determined individually by the prescribing clinician.

Follow all instructions printed on the pharmacy label. Do not self-administer unless you have received appropriate training and clinical clearance.

Typical practitioner-directed use may include:
Route: Subcutaneous injection via pre-filled BPC-157 pen.
Injection site: Inject close to the injured structure, within the surrounding soft tissue or regional subcutaneous area, unless otherwise directed.
Pattern: Daily dosing, prioritising localised delivery to support tendon, ligament, and soft-tissue repair pathways.
Cycle: Continuous daily administration throughout the prescribed course (BPC-157 is not typically cycled).
Technique: Clean the skin with an alcohol swab, administer as instructed, and dispose of the used needle safely after each injection.
Rotation: Slightly vary injection points around the target region to minimise irritation while maintaining local tissue exposure.

All dosing parameters (including injection volume, proximity to the injury, and total course duration) are determined by the prescribing clinician based on healing goals and individual response.

Safety & Precautions

Schedule 4 (Prescription-Only) – must be prescribed and supervised by a qualified clinician.
Disclose all existing conditions, allergies, and concurrent medications before use.
Not recommended during pregnancy or breastfeeding unless specifically approved by a practitioner.
Report any irritation, redness, or unexpected symptoms to your prescriber or pharmacist.
Store and handle exactly as directed by your dispensing pharmacy.

Research Context

BPC-157 remains an active topic in regenerative and integrative medicine research.

Pre-clinical evidence points toward effects on angiogenesis, nitric-oxide regulation, and cytokine modulation, yet large-scale human trials are still limited. All use in Australia occurs under off-label, prescription-based compounding frameworks, guided by clinician oversight.

Further studies are needed to define long-term safety, pharmacokinetics, and reproducible dosing outcomes.

Disclaimer

Educational content only; not medical advice.

BPC-157 compounded injectables are not registered with the Therapeutic Goods Administration (TGA) and no therapeutic claims are made.

Use only under consultation and prescription from a registered healthcare professional.
Buy Now, Pay Later with
Earn Points while you Drip with
           

Mobile IV Drip

NAD+ Subcutaneous Pen

NAD+ Subcutaneous injection

NAD+ Infusion

Melbourne NAD+

Brisbane NAD+

Gold Coast NAD+

NAD+ at Home

NAD+

PT-141

Sydney NAD+

NAD+ Injection

NAD+ Australia

BPC-157

Bio-hacking NAD+

anti-aging NAD+

nad+ Injection

Mobile IV drip NAD+

Mobile IV drip NAD+ Melbourne

Mobile IV drip NAD+ Brisbane

Mobile IV drip NAD+ Sydney

Mobile IV drip NAD+ Gold Coast

NAD+ drip at home Melbourne

At home nad+

IV nad

Hydration drip

NAD drip

NAD infusion

IV NAD infusion

NAD drip mobile

NAD IV drip

NAD IV

nad at home

Inject+ Disclaimer

By continuing, you acknowledge and agree to the following terms and conditions of ExclusIV by Mobile IV Drip:

1. Elective Wellness Services
All IV infusions and subcutaneous products offered through Mobile IV Drip are elective wellness services. They are not prescribed or promoted as medically necessary treatments and are designed to support general wellness and vitality.

2. No Public Advertising
The information displayed in this section is provided privately on request and does not constitute public advertising.

3. No Medical or Therapeutic Claims
No statements here should be interpreted as claims of therapeutic benefit. Services and compounded formulations are not a substitute for professional medical advice, prescribed medication, or conventional treatment.

4. Practitioner Review Required
Before any compounded or prescription-only product is supplied, clients are required to complete medical intake and be reviewed by an authorised prescriber and/or nurse practitioner, and obtain a prescription where required.

5. Pricing
Pricing shown is indicative only and may change following clinical assessment, prescription requirements, or compounding variables. Final costs are confirmed after prescriber approval.

6. Voluntary Request
You confirm you are voluntarily requesting this information for personal education, and that access does not guarantee suitability for every option listed.

7. Privacy
Any information you provide may be used to communicate about consultations, prescriptions or updates, with opt-out available.

By selecting “I want ExclusIV access”, you confirm you have read and understood the above.